Online inquiry

IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21475MR)

This product GTTS-WK21475MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Androgen-binding protein protein. This product can be used in Sertoli cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001040.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 6462
UniProt ID P04278
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21475MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK23727MR IVTScrip™ mRNA-Human APOC1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APOC1
GTTS-WK16289MR IVTScrip™ mRNA-Human ALB, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ALB
GTTS-WK21917MR IVTScrip™ mRNA-Human APOA4, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APOA4
GTTS-WK1339MR IVTScrip™ mRNA-Human CRIP1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA CRIP1
GTTS-WK24580MR IVTScrip™ mRNA-Human ATP13A3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ATP13A3
GTTS-WK21278MR IVTScrip™ mRNA-Human AP1S3, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AP1S3
GTTS-WK23453MR IVTScrip™ mRNA-Human AQP9, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AQP9
GTTS-WK21586MR IVTScrip™ mRNA-Human AP3D1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AP3D1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW